论文部分内容阅读
目的观察丁苯酞联合依达拉奉对进展性脑梗死的治疗效果。方法将106例进展性脑梗死患者随机分成观察组和对照组,每组53例。观察组用丁苯酞100ml、q12、14d,依达拉奉30mg+生理盐水250ml、1次/d、14d。对照组采用血塞通针400mg+生理盐水250ml、1次/d、14d。结果观察组、对照组总有效率分别为94%、79%,差异有统计学意义(P<0.05)。结论丁苯酞联合依达拉奉治疗进展性脑梗死安全有效,疗效显著。
Objective To observe the therapeutic effect of butylphthalide and edaravone on progressive cerebral infarction. Methods 106 patients with progressive cerebral infarction were randomly divided into observation group and control group, with 53 cases in each group. Observation group with butylphthalide 100ml, q12, 14d, edaravone 30mg + saline 250ml, 1 time / d, 14d. The control group used Xuesaitong 400mg + saline 250ml, 1 time / d, 14d. Results The total effective rate in observation group and control group was 94% and 79%, respectively, with significant difference (P <0.05). Conclusion Butylphthalide combined with edaravone is safe and effective in treating progressive cerebral infarction.